In addition to traditional and RA-specific risk factors for CVD, biomarkers of cardiac dysfunction, including N-terminal pro-brain natriuretic peptide (NT-proBNP) and cardiac troponin T, have also been reported to predict CVD risk and mortality in RA patients [46]. The gene discussed is NPPB; the disease is rheumatoid arthritis.